Biosafety Regulation in Zimbabwe

Slides:



Advertisements
Similar presentations
National Herbarium & Botanic Gardens of Malawi
Advertisements

The Role of Customs Officers in Implementing the Protocol GRULAC Regional Training of Trainers Workshop on the Identification and Documentation of LMOs.
Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
Erie Tamale Secretariat of the Convention on Biological Diversity
“Towards a Regional Approach to Biotechnology Policy in Southern Africa “ By Lindiwe Majele Sibanda
Suzanne Davis Senior Research Officer – Jamaica Clearing-House Mechanism Natural History Division Institute of Jamaica.
INCEPTION WORKSHOP BACKGROUND PAPER BIOSAFETY IMPLEMENTATION PROJECT FOR ARAB REPUBLIC OF EGYPT GEF/UNEP DR. NERMEEN EL-TAYEB ASSISTANT TO THE INTERIM.
BIOSAFETY IN HEALTH RESEARCH Annah R. Takombwa – Acting Technical Affairs Manager, National Biotechnology Authority.
RATIFICATION OF FINAL ACTS AND DECISIONS OF THE 1999 BEIJING CONGRESS – UNIVERSAL POSTAL UNION.
Overview Summary from Africa and ASEAN assistance Dr. Peter Pembleton, UNIDO.
DEPARTMENT: AGRICULTURE Genetically Modified Organisms Act, 1997 (Act No. 15 of 1997) By Shadrack R. Moephuli (Dr.) Registrar: GMO Act 14 April 2003.
GENETICALLY MODIFIED ORGANISM PRESENTATION 13 September 2013 By Department of Trade and Industry.
Biosecurity Laws and Regulations in Turkey Prof. Dr. Hüseyin Avni Öktem Nanobiotechnology R&D Group, Department of Biological Sciences Middle East Technical.
Aflatoxins in Zimbabwe Legislative Frameworks Against Level of Awareness A Perspective from a Laboratory Paper presented by Nozipo Nziramasanga At Huang.
Presidency of Council of Ministers National Committee for Biosafety, Biotechnology and Life Sciences (D.P.C.M. March 19, 2007)
Cartagena protocol on Biosafety to the Convention on Biological Diversity and the International debates (COP- MOP) Stakeholders’ workshop on the Biosafety.
Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,
Thailand NUCLEAR POWER PROGRAM INFRASTRUCTURE AND STATUS OF IMPLEMENTATION: Regulatory Body Prof. Dr. Chaivat TOSKULKAO Secretary General Office of Atoms.
1 Inter-linkages: BCH, Parties, Capacity Building, Compliance and RA Concept Sustainability Biosafety Programme - Secretariat of the Convention on Biological.
DEPARTMENT: AGRICULTURE CARTAGENA PROTOCOL ON BIOSAFETY TO THE CONVENTION ON BIOLOGICAL DIVERSITY By Shadrack R. Moephuli (Dr.) Registrar: GMO Act 5 August.
Department of Science and Technology: Role in the administration, utilization and management of GM food Ben Durham Chief Director Biotechnology and Health.
Confronting Contamination: Biosafety Lim Li Lin, Third World Network.
Training Workshop for Regional Advisors Bangkok, Thailand 15 – 27 May 2006.
Australia’s policy and regulatory framework for gene technology QMAC 2003 (Dr) Sue D Meek Gene Technology Regulator.
Cooperation between the African Union (AU) and the German Federal Ministry for Economic Co-operation and Development (BMZ) in biosafety issues.
STATUS OF UNEP/GEF NATIONAL BIOSAFETY FRAMEWORK IMPLEMENTATION PROJECT BY RUFUS EBEGBA FEDERAL MINISTRY OF ENVIRONMENT 22 APRIL 2014.
Putting Biotechnology into Practice in International Development Josette Lewis, Ph.D. USAID.
Creating a Conducive Environment for Biotechnology: The Cartagena Protocol as an Enabling Framework Drew L. Kershen Earl Sneed Centennial Professor University.
GMO AMENDMENT BILL DEPARTMENT OF AGRICULTURE REPRESENTATIVES DR. SHADRACK R. MOEPHULI:ADGAP (EC: CHAIR) DR. JULIAN B. JAFTHA: SMGRM MS. MICHELLE.
Introduction to the Obligations of the Party to the Biosafety Clearing-House Manoranjan Hota.
GMO AMENDMENT BILL PRESENTERS  Julian JafthaDoA  Ben DurhamDST  Leseho SelloDEAT  Modiegi SelematselaDoH  Ndivhou RabuliDoA  Mbudzeni SibaraAdvisory.
THE BIOSAFETY BILL, 2007 JACARANDA HOTEL, 26 TH JULY 2007.
1 Basel Convention on the Control of Transboundary Movement of Hazardous Wastes and Their Disposal Brief background The Convention Implementation actors.
CARTAGENA PROTOCOL ON BIOSAFETY NDA- DEAT BILATERAL MEETING 1 August 2003 Presenter : M. Mbengashe.
Biodiversity Cooperation. CITES * CITES (1973): Convention on International Trade in Endangered Species of Fauna and Flora *Regulates trade in living.
Biotechnology Priorities for South Africa Prof. Diran Makinde AfricaBio Cape Town- 14/15 April 2003.
AGRICULTURAL PRODUCT INSPECTION SERVICES Mooketsa Ramasodi Directorate Agricultural Product Inspection Services Trade Awareness Workshop Polokwane, 13.
Slide No. 1 Pradeep S Mehta Secretary General CUTS International Jaipur, India International Trade Concerns Effects of International.
Perspective on OECD activities from a non-member country Prof. Atanas Atanassov, Agrobioinstitute, BULGARIA workshop: Beyond the Blue Book: Framework for.
GMO amendment Bill and biotech policy W. De Greef, Consultant to AfricaBio.
Guatemala: An evaluation of Biosafety Regulations Drew L. Kershen Earl Sneed Centennial Professor Univ. of Oklahoma, College of Law Copyright 2007, all.
BRIEFING ON GENETICALLY MODIFIED ORGANISMS A CTING DIRECTOR GENERAL : MR PETER THABETE D EPARTMENT OF AGRICULTURE, FISHERIES AND FORESTRY.
International Centre for Genetic Engineering and Biotechnology (ICGEB) Presentation to NCOP Select Committee On Education and Recreation Dhesigen Naidoo.
Cartagena Protocol on Biosafety Cartagena Protocol on Biosafety And India’s Obligations By Desh Deepak Verma Joint Secretary, Ministry of Environment and.
Introduction to the Biosafety Clearing-House. footer What is the role of the BCH? Under Art 20, the CPB established the BCH. The Protocol sets out two.
AGRICULTURAL PRODUCT INSPECTION SERVICES Mooketsa Ramasodi Directorate Agricultural Product Inspection Services Trade Awareness Workshop Polokwane, 12.
STDF WORKSHOP ON SPS CAPACITY EVALUATION TOOLS 31 March 2008 Erie Tamale, Programme Officer Secretariat of the Convention on Biological Diversity
South African Biosafety Regulatory Framework Julian Jaftha Director: Genetic Resources Management.
GMO AMENDMENT BILL INTRODUCTION TO GMO ACT (Act No. 15 of 1997)  SAGENE: Advisory role Responsible for evaluation of risk assessment data Amendment.
1 DEAT PERSPECTIVE ON GENETICALLY MODIFIED ORGANISMS 31 JULY 2007.
Capacity Building for the implementation of the Cartagena Protocol on Biosafety by the German Development Co-operation: German Federal Ministry for Economic.
Ratification of BWC BWC Expert Group, Republic of Korea Compendium of National Activities in Korea: Measures to Improve Biosafety and Biosecurity Hei Chan.
Romanian framework concerning GMOs Dr. Valeria GAGIU Institute of Food Bioresources 6 Dinu Vintila Street, , 2 nd district, Bucharest ROMANIA Tel.
Priority Agricultural Policies and Standards to Advance Agricultural Trade and Access to Inputs Regional Feed the Future and Trade Africa Meeting
Russian Information-Analytical APEC Center for Agricultural Biotechnology.
DEPARTMENT OF BIOSAFETY MINISTRY OF NATURAL RESOURCES & ENVIRONMENT
Agricultural Biotechnology in Turkey
13 September 2013 By Department of Trade and Industry
Designing a Dynamic IP System in the Republic of Belarus
Biosafety Regulation in Zimbabwe
THE NON-BIOLOGICAL FACTORS THAT IMPACT BIOTECH INNOVATION
Biotech Plants Two Different Visions and their Implications in Global Trading Carlos Moreira “Plants for Life” International PhD Program – 2017 (course.
Genetically Modified Organisms Act, 1997 (Act No. 15 of 1997)
Cooperation between the
GMO AMENDMENT BILL 2005.
Aflatoxins in Zimbabwe Legislative Frameworks Against Level of Awareness A Perspective from a Laboratory Paper presented by Nozipo Nziramasanga At Huang.
ROLE OF KEPHIS IN SAFE HANDLING, TRANSFER AND USE OF GMOS.
Cartagena Protocol on Biosafety -Reducing the Environmental Risks of Modern Biotechnology Secretariat of the Convention on Biological Diversity
Genetically Modified Organisms Act, 1997 (Act No. 15 of 1997)
Introduction to the Obligations of the Party to the Biosafety Clearing-House Manoranjan Hota.
Presentation transcript:

Biosafety Regulation in Zimbabwe Dr. J.Mufandaedza – Chief Executive Officer & Registrar , National Biotechnology Authority

WHO IS NBA? It is a strategic arm of the Government of Zimbabwe, established through the National Biotechnology Authority Act [Chap. 14:31] of 2006. National Competent Authority for all biotechnology, biosafety and biosecurity matters including GMOs.

BACKGROUND 1998 - Research Act amended to provide for the management of potentially harmful technologies and undertakings. The Biosafety Board was formed. 2005 - Zimbabwe ratifies the Cartagena Protocol on Biosafety (CPB) and the National Biotechnology Policy was developed with support from UNEP-GEF.

BACKGROUND cont... 2006 - the NBA Act [Chap.14:31] of 2006 was gazetted. This gave rise to the National Biotechnology Authority. NBA’s mandate further emphasised in 2rd Science Technology and Innovation Policy of 2012.

But what is the GM technology which we regulate Biotechnology from our point of view as NBA looks at Industrial biotech Pharmaceutical/ medical biotech Agricultural/crop biotech Food biotech

contd It also focuses on regulation of related technologies such nanotechnlongy, symthetic biology metabolic engineering, proteomics, metabolomics, DNA-chip technology, bioinformatics

Zimbabwe`s Biosafety Framework It comprises of: National Biotechnology Policy; An Act of Parliament - the NBA Act; Institutional arrangements - NBA & Institutional Biosafety Committees (IBCs); Mechanisms for risk assessment (reviews); mechanisms for decision making (NBA); mechanisms for public consultation; mechanisms for monitoring and enforcement (Biosafety Inspectorate); supporting guidelines and standards.

NBA Act of 2006 applies to: All research activities involved in development, importation, exportation and use of biotechnological processes; import, export, contained use, release of any product of biotech that is likely to have adverse effect on human health, environment, economy, national security or social norms and values; Any activity involving biological /molecular engineering technologies (metabolic engineering, proteomics, metabolomics, nanotechnology, cloning, DNA-chip technology, bioinformatics and other technologies declared by the Authority to constitute potentially harmful research or undertakings All measures aimed at minimising impact of biotechnological processes on national security, human health, animals, plants environment.

Corporate governance and management structure Minister for the MHTESTD NBA Board National Biotechnology Authority Chief Executive Officer & Registrar Regulatory Affairs Public Awareness Research Support Finance and Administration

NBA Mandate In accordance with the NBA Act, the functions of the Authority are: To advise the Minister on all aspects concerning the development, production, use, application and release of products of biotechnology. To regulate biotechnology research, development, production, use, application, movement and release of products thereof. To provide programmes on public awareness and understanding of biotech and biosafety. To provide infrastructural capacity and human capital development. To administer the Biotech Fund on behalf of the Minister.

NBA`s Services Regulatory Services Research Support Services Public Awareness and Education Advisory Services

Research Support Services Administering the Biotechnology Fund. Conducting operational research. National Biosafety Reference Lab with biosafety levels BSL1-BSL4

Public Awareness Training & Education Conducting biotechnology awareness : Public exhibitions Outreach programmes for farmers , students etc.

Public Awareness Training & Education Producing awareness and education material. Training legislature/stakeholders on biotech through workshops/meetings

Regulatory Function Issuance of permits and certificates. Pre and post shipment inspections of imports and exports. Monitoring imports and exports at ports. Registration of biotechnology facilities. Biosafety policy development. Assessment of potential release of GMOs into the environment (GMO surveillance and Testing). Supervision of contained use, trial and general release of biotechnology products.

GMOs in Zimbabwe Zimbabwe has not yet approved the commercialization of GM crops or animals. Confined field trials for Bt maize and cotton conducted from 2001 – 2005. Importation of GM positive material is highly regulated. Research on GMOs is not ruled out.

Cartagena Protocol on Biosafety Influential in the improvement of the National Biosafety Framework Zimbabwe has been a party to the Cartagena Protocol on Biosafety since 2005 NBA is the Competent Authority for the Protocol and the National Focal Point and National Competent Authority for the BCH

Effective regulation SPS regulatory agents PQS EMA MCAZ RCZ MRC PORT HEALTH

Global Biotech Regulation

Biotech and Biosafety legislation in Africa Different regulations governing the use and application of biotech exists in Africa. African Union acknowledges that the need for African countries to have a harmonized position on Biotech and Biosafety: Modern law on biosafety SADC has draft guidelines for addressing issues of GMOs and Biotech. COMESA has a regional policy on commercial planting, trade and emergency food assistance involving GMOs: Regional Approach to Biotechnology and Biosafety policy in Eastern and Southern Africa (RABESA).

Biotech and Biosafety legislation in Africa

Concerns Around Biotech in the midst of Scientific Optimism in Africa Biotech concerns have global, regional and national dimensions . Other countries have adopted biotech while others have adopted a precautionary approach

Major concerns to GM Revolve around safety to humans and animals consuming GM products, Plants and insects in the environments where crops are grown. In Africa, there is wide belief that GM crops are intended for use in industrialized countries, and are hence inappropriate for agriculture Africa.

Biotech concerns Trade concern that GM crops replaces conventional varieties and make farmers dependent on private seed companies. Capacities to undertake research and monitor and evaluate GM products Loss of export markets for specific crops to trade-sensitive countries has also been expressed. These fears stem from uncertainty over those who gain or lose from the technology.

Major concern Socio-economic considerations for the regulator Cultural Religious Reliefs spiritual

Elswhere Different countries have different legislations/policies or stances on GMOs. Some countries have imposed labelling of GMO products. Most countries (170) implement the Cartagena Protocol on Biosafety.

NBA Prospects Prospects Lobby Government to release funds for the Biotech Fund. Ratification to the Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety and the International Centre for Genetic Engineering and Biotechnology (ICGEB) treaty. Development of the National Biosafety Clearing House Increase public awareness. Encourage more biotechnology and biosafety research.

Thank you For More Information Contact: 21 Princess Drive Newlands P. O. Box CY379 Harare Tel: +263 4 782856/9 Email: nba@nba.ac.zw Website: www.nba.ac.zw